» Articles » PMID: 32089922

Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy

Overview
Publisher Wiley
Specialty Oncology
Date 2020 Feb 25
PMID 32089922
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Carcinoma ex pleomorphic adenoma (Ca ex PA) is a rare malignant transformation of a benign primary pleomorphic adenoma (PA). We report the case of a 62-year-old male who presented with a swelling over his left temple. Imaging revealed a lytic lesion over the left orbital wall with soft tissue extension suggestive of malignancy. He underwent an en bloc resection of the mass with orbital exenteration, craniotomy, and reconstruction. Pathology demonstrated a lacrimal gland ductal adenocarcinoma arising from a PA which led to the diagnosis of ductal adenoCa ex PA. Postoperatively, he received chemotherapy with 6 cycles of cisplatin and concurrent radiation therapy (RT), but his course was complicated by recurrent bacterial meningitis and abscesses and he ultimately opted for comfort measures. Patients with PA of the lacrimal gland experience an insidiously enlarging painless swelling of the orbit with transformation to Ca ex PA highlighted by a rapid onset of bulbar enlargement, displacement, and often proptosis. Ductal adenoCa ex PA is aggressive with a poor prognosis and has no established standard of care. This case highlights the rarity of this condition and the need for more literature to help direct treatment.

Citing Articles

The poor prognosis of lacrimal gland adenocarcinoma: a clinical study and literature review.

Liu R, Ren T, Li J, Wang N, Xu L, Guo Q J Cancer Res Clin Oncol. 2024; 150(1):26.

PMID: 38263473 PMC: 10806072. DOI: 10.1007/s00432-023-05510-7.


Current Trends in the Management of Epithelial Lacrimal Gland Tumors: A Retrospective National Cancer Database Analysis.

Ashok Kumar P, Wang D, Huang D, Paulraj S, Sivapiragasam A Cureus. 2022; 14(7):e27109.

PMID: 36000118 PMC: 9391612. DOI: 10.7759/cureus.27109.


Proptosis Revealing a Rare Lacrimal Gland Tumor: A Case of Chondroid Syringoma in a 35-year-old Patient.

Efared B, Kadre Alio K, Idrissa B, Bako A, Boureima H, Saleye A Clin Pathol. 2022; 15:2632010X211070777.

PMID: 35036913 PMC: 8753070. DOI: 10.1177/2632010X211070777.


Clinical analysis of 109 cases of lacrimal gland pleomorphic adenoma.

Liu R, Wang N, Zhang H, Ge X, Ma J Int J Ophthalmol. 2021; 14(12):1852-1857.

PMID: 34926199 PMC: 8640764. DOI: 10.18240/ijo.2021.12.07.

References
1.
von Holstein S, Coupland S, Briscoe D, Le Tourneau C, Heegaard S . Epithelial tumours of the lacrimal gland: a clinical, histopathological, surgical and oncological survey. Acta Ophthalmol. 2012; 91(3):195-206. DOI: 10.1111/j.1755-3768.2012.02402.x. View

2.
Altemani A, Martins M, Freitas L, Soares F, Araujo N, Araujo V . Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology. 2005; 46(6):635-41. DOI: 10.1111/j.1365-2559.2005.02157.x. View

3.
Daniel L, Rao S, Muthusamy R, Yerramsetti D . Mucoepidermoid carcinoma ex pleomorphic adenoma of the lacrimal gland: a rare presentation. Indian J Ophthalmol. 2014; 62(6):743-6. PMC: 4131338. DOI: 10.4103/0301-4738.136281. View

4.
Zhang P, Tang L, Gao H, Zhang W, Lin J, Yang H . Immunohistochemical features of carcinoma ex pleomorphic adenoma and pleomorphic adenoma in the lacrimal gland. Int J Ophthalmol. 2019; 12(8):1238-1242. PMC: 6694048. DOI: 10.18240/ijo.2019.08.02. View

5.
Venkatesulu B, Pathy S, Vallonthaiel A, Chawla B . Epithelial-myoepithelial carcinoma of lacrimal gland from an ex pleomorphic adenoma. BMJ Case Rep. 2015; 2015. PMC: 4521531. DOI: 10.1136/bcr-2015-210795. View